Efficacy and Safety of Cholera Vaccines

Efficacy and Safety of Cholera Vaccines

Cholera is an acute diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and O139 serogroups. It still remains a major global healthcare problem. According to WHO, about 100,000 people die from cholera every year, despite the modern methods of treatment, improvement in the quality o...

Full description

Bibliographic Details
Main Authors:	A. A. Goryaev, L. V. Sayapina, Yu. I. Obukhov, V. P. Bondarev
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-03-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	cholera vaccines cholera vaccines live vaccines inactivated vaccines cholera prevention vibrio cholerae
Online Access:	https://www.biopreparations.ru/jour/article/view/120

Similar Items

Cholera pulse vaccination: A possible elimination strategy for cholera in endemic countries
by: Neelam Taneja, et al.
Published: (2021-01-01)

Cholera, the Current Status of Cholera Vaccines and Recommendations for Travellers
by: Giovanni Gabutti, et al.
Published: (2020-10-01)

Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development
by: David A. Montero, et al.
Published: (2023-05-01)

Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era
by: Sachin N. Desai, et al.
Published: (2017-03-01)

PaxVax CVD 103-HgR single-dose live oral cholera vaccine
by: Myron M. Levine, et al.
Published: (2017-03-01)

Oral Cholera Vaccine Efficacy and Effectiveness
by: Katerina Rok Song, et al.
Published: (2021-12-01)

An overview of VaxchoraTM, a live attenuated oral cholera vaccine
by: Tarun Saluja, et al.
Published: (2020-01-01)

Experimental Substantiation of Feasibility of Using Enzymatic Fibrin Hydrolyzate-Based Medium to Obtain Components of Chemical Cholera Vaccine
by: V. R. Vol’nikov, et al.
Published: (2023-07-01)

Antigenic Components of Chemical Bivalent Cholera Vaccine, Methods of their Isolation and Control
by: S. A. Vorob’eva, et al.
Published: (2022-07-01)

Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010−2011
by: Kashmira A. Date, et al.
Published: (2011-11-01)

An Update on Cholera Immunity and Current and Future Cholera Vaccines
by: Jan Holmgren
Published: (2021-04-01)

Design and Construction of Vibrio cholerae Strains That Harbor Various CTX Prophage Arrays
by: Hyun J. Yu, et al.
Published: (2018-03-01)

Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform
by: Julie Liao, et al.
Published: (2018-06-01)

Evaluation of ctxA gene expression of Vibrio cholerae strain 569B in the production of cholera vaccine
by: Vorobyova, Svetlana A., et al.
Published: (2022-09-01)

Fishing for vaccines against Vibrio cholerae using in silico pan-proteomic reverse vaccinology approach
by: Muhammad I. Rashid, et al.
Published: (2019-06-01)

The influence of immunomodulators on the formation of vaccine-induced cholera immunity
by: A. V. Filippenko, et al.
Published: (2022-03-01)

In vivo evaluation of microencapsulated bicistronic plasmid DNA vaccine against Vibrio cholerae
by: Ahmad Zamri, Najwa
Published: (2021)

The reactive cholera vaccination campaign in urban Dhaka in 2022: experience, lessons learned and future directions
by: Zahid Hasan Khan, et al.
Published: (2024-06-01)

Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment
by: Jacqueline Deen, et al.
Published: (2021-03-01)

Principles of Quantitative Morphometric Assessment of Cholera Vaccines Safety
by: S. A. Bugorkova, et al.
Published: (2011-04-01)

The case for ring vaccinations with special consideration of oral cholera vaccines
by: Jacqueline Deen, et al.
Published: (2018-08-01)

Investigating the stability of the Properties of Vibrio cholerae strains – Producers of Active Components of the Chemical Cholera Vaccine
by: O. S. Durakova, et al.
Published: (2022-07-01)

Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh
by: M. Hasanul Kaisar, et al.
Published: (2023-10-01)

<italic toggle="yes">Vibrio cholerae</italic> at the Intersection of Immunity and the Microbiome
by: Ana A. Weil, et al.
Published: (2019-12-01)

Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model
by: Shaghayegh Anvari, et al.
Published: (2018-09-01)

IMPROVEMENT OF SPECIFIC CHOLERA PREVENTION USING IMMUNOMODULATORS
by: A. V. Filippenko, et al.
Published: (2021-10-01)

Cholera vaccine clinical trials: A cross-sectional analysis of clinical trials registries
by: Lindi Mathebula, et al.
Published: (2023-08-01)

Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam
by: Trach D.D., et al.
Published: (2002-01-01)

A scoping review of facilitators and barriers influencing the implementation of surveillance and oral cholera vaccine interventions for cholera control in lower- and middle-income countries
by: Hanna Trolle, et al.
Published: (2023-03-01)

Mapping the high burden areas of cholera in Nepal for potential use of oral cholera vaccine: An analysis of data from publications and routine surveillance systems
by: Chulwoo Rhee, et al.
Published: (2020-01-01)

Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 2013
by: Rania A. Tohme, et al.
Published: (2015-06-01)

Correlation between antibody titers in human serum and plasma prepared with EDTA for the assessment of cholera vaccine immune responses
by: Talena Ledón-Pérez, et al.
Published: (2017-06-01)

Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera
by: Mohammad Ali, et al.
Published: (2018-01-01)

Comparison of analysis methods to classify cholera hotspots in Ethiopia from 2015 to 2021
by: Yeshambel Worku Demlie, et al.
Published: (2024-04-01)

Cholera Toxin B: One Subunit with Many Pharmaceutical Applications
by: Keegan J. Baldauf, et al.
Published: (2015-03-01)

Cholera Specific Prophylaxis in Modern Conditions
by: G. G. Onishchenko, et al.
Published: (2011-02-01)

Examination of Processes of Cultivation of <i>V. cholerae</i> strains - Producers of Protective Antigens of Cholera Bivalent Chemical Vaccine in Tablets - in the Engineered Bioreactor
by: A. K. Nikiforov, et al.
Published: (2012-04-01)

Serotyping and Phage Typing of Vibrio cholerae Isolated AtTertiary Care Hospital, Ahmedabad, Gujarat
by: Leuva LM, et al.
Published: (2023-12-01)

Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia
by: Samuel Teshome, et al.
Published: (2018-10-01)

Vibrio cholerae O139
by: Işın AKYAR, et al.
Published: (1997-03-01)